Literature DB >> 10409297

Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet.

K P Conrad1, L J Kerchner, M D Mosher.   

Abstract

We tested the hypothesis that nitric oxide (NO) biosynthesis increases during normal human pregnancy and decreases in preeclampsia. The major metabolites of NO, nitrate and nitrite (NO(x)), were measured in both the plasma and 24-h urine of women subjected to a reduced NO(x) diet. In this way, the plasma and urinary levels mainly reflected endogenous production rather than dietary intake. Moreover, we assessed cGMP, a second messenger of NO, in the same samples. Both NO(x) and cGMP assays were validated in our laboratory. We first conducted a cross-sectional study of nonpregnant women (n = 15), normal pregnant women in the first (n = 9), second (n = 17) and third (n = 22) trimesters, as well as women with preeclampsia (n = 15) and transient hypertension of pregnancy (n = 7). We also performed a serial study in the same women (n = 9) before, during, and after pregnancy. Taken together, the results of the two investigations suggested marked increases in cGMP production especially during the first trimester when the maternal circulation is rapidly vasodilating. In contrast, whole body NO production as estimated by the plasma level and urinary excretion of NO(x) was not elevated during the first trimester. Finally, unequivocal demonstration of reduced NO biosynthesis in preeclampsia was not forthcoming.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10409297     DOI: 10.1152/ajprenal.1999.277.1.F48

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  33 in total

Review 1.  Impact of pregnancy on underlying renal disease.

Authors:  Chris Baylis
Journal:  Adv Ren Replace Ther       Date:  2003-01

2.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

3.  Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2012-08

4.  The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2010-04

Review 5.  Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Authors:  Babbette D LaMarca; Jeffery Gilbert; Joey P Granger
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

Review 6.  Phosphodiesterase Inhibition in the Treatment of Preeclampsia: What Is New?

Authors:  Anne Brandolt Larré; Fernando Sontag; Débora Montenegro Pasin; Nathália Paludo; Rayssa Ruszkowski do Amaral; Bartira Ercília Pinheiro da Costa; Carlos Eduardo Poli-de-Figueiredo
Journal:  Curr Hypertens Rep       Date:  2018-07-26       Impact factor: 5.369

Review 7.  Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.

Authors:  Dania A Shah; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2015-04-24       Impact factor: 5.858

8.  Effects of sildenafil on maternal hemodynamics and fetal growth in normal rat pregnancy.

Authors:  Jennifer M Sasser; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-02       Impact factor: 3.619

9.  Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.

Authors:  J S Possomato-Vieira; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-06-14

Review 10.  Vasodilator factors in the systemic and local adaptations to pregnancy.

Authors:  Gloria Valdes; Peter Kaufmann; Jenny Corthorn; Rafaela Erices; K Bridget Brosnihan; Janae Joyner-Grantham
Journal:  Reprod Biol Endocrinol       Date:  2009-07-31       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.